Trovato Emanuele

23PUBLICATIONS
137CO-AUTHORS
Field organic and low chemical input horticultureAllergyInnate immunityAutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 17, 2026
Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.

|Jun 25, 2026
Systemic Immune-Inflammation Index (SII) as a Predictive Biomarker of Therapeutic Response in Psoriasis: A Retrospective Comparative Analysis of Anti-TNF, Anti-IL-17, and Anti-IL-23 Agents.

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

|Nov 26, 2025
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

A Carugno, G Nazzaro, L Argnani

|Sep 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results.

Bianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni

|Jun 16, 2025
Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective study.

Francesca Satolli, Silvia Gerosa, Martina Burlando

Pageof 4

Frequent Collaborators

7 joint publications

Francesca Prignano

7 joint publications

Paolo Gisondi

6 joint publications

Simone Ribero

5 joint publications

Martina Dragotto